Showing results (131-140 of 228) with videos related to
Sort By:
Pageof 23
The Journal of Urology|March 21, 1998
The use of percent free prostate specific antigen for staging clinically localized prostate cancerJ Pannek, H G Rittenhouse, D W Chan, et al.The Journal of Urology|April 1, 1996
Standard versus age-specific prostate specific antigen reference ranges among men with clinically localized prostate cancer: A pathological analysisA W Partin, S R Criley, E N Subong, et al.Journal of Pediatric Surgery|March 1, 1994
Prediction of disease-free survival after therapy in Wilms' tumor using nuclear morphometric techniquesA W Partin, J K Yoo, D Crooks, et al.The Journal of Rheumatology|December 1, 1985
Fibroblast growth factors in sclerodermaS R Potter, J Bienenstock, S Goldstein, et al.Urology|December 18, 2001
Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millenniumA W Partin, L A Mangold, D M Lamm, et al.The Prostate|May 27, 1999
Monoclonal antibody to prostate cancer nuclear matrix protein (PRO:4-216) recognizes nucleophosmin/B23E N Subong, M J Shue, J I Epstein, et al.JAMA|May 11, 1999
Natural history of progression after PSA elevation following radical prostatectomyC R Pound, A W Partin, M A Eisenberger, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Nuclear morphometry and prognosis in favorable histology Wilms' tumor: A prospective reevaluationN E Breslow, A W Partin, B R Lee, et al.The Journal of Urology|March 1, 1995
Deoxyribonucleic acid ploidy analysis as a predictor of recurrence following radical prostatectomy for stage T2 diseaseM J Carmichael, R W Veltri, A W Partin, et al.Urology|July 1, 1994
Telerobotic assisted laparoscopic surgery: initial laboratory and clinical experienceL R Kavoussi, R G Moore, A W Partin, et al.Pageof 23